APR 25, 2017 10:00 AM PDT

WEBINAR: Discover Potentially Predictive Immuno-Oncology Biomarkers using Next-Gen Sequencing

Speakers

Abstract

DATE: April 25, 2017
TIME: 10:00am PT, 1:00pm ET

Immunotherapy has emerged as one of the most promising options for the future treatment of a growing number of cancers and is touted to be the next revolution in our fight against this complex disease. One of the most effective modalities of treatment, thus far, has been in the form of immune checkpoint inhibitors such as PD-1 and PD-L1 inhibitors.

Current biomarkers and immunohistochemistry (IHC) assays are not accurate predictors of which individuals are most likely to respond or benefit from immunotherapeutic agents, thus prompting the need to identify better biomarkers that can guide therapy selection in the future. 

Next-generation sequencing (NGS) offers clinical researchers a cost-efficient and rapid way of analyzing multiple targets simultaneously from as little as 10ng of total RNA isolated from formalin-fixed, paraffin-embedded (FFPE) samples.  

In this webinar, our speakers will show how Thermo Fisher Scientific’s Oncomine Immune Response Research Assay enables the interrogation of gene targets that are critical for research into immune response.
 
Topics to be covered:

  • Fiona Hyland will describe how the content for a new gene expression NGS-based assay was carefully selected and will compare its performance against other assay(s) available on the market.
  • Dr. Carl Morrison will describe a verification study for establishing the performance of the new Oncomine Immune Response Research Assay in a clinical research lab.

Key learning objectives for attendees:

  • How to improve immuno-oncology biomarker discovery using NGS
  • Benefits of applying a targeted gene-expression based approach for studying the tumor microenvironment
  • How to implement the Oncomine Immune Response Research Assay in a clinical research lab 

Who should attend:

  • Scientists involved in biomarker discovery and drug development 
  • Contract Research Organizations focused on oncology services
  • Immunology and oncology translational/clinical research laboratories interested in adopting NGS


For Research Use Only. Not for use in diagnostic procedures.


Show Resources
You May Also Like
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
NOV 17, 2021 8:00 AM PST
C.E. CREDITS
NOV 17, 2021 8:00 AM PST
Date: November 17, 2021 Time: 8:00am (PDT), 11:00am (EDT) From waste disposal to promising biomarkers and therapeutic agents, exosomes and other extracellular vesicles are valuable in resear...
JUL 15, 2021 9:00 AM PDT
JUL 15, 2021 9:00 AM PDT
Date: July 15, 2021 Time: 9:00am (PDT), 12:00pm (EDT) The Pisces workflow robust, easy-to-use, end-to-end multi-omics solution for highly multiplexed targeted Spatial RNA analysis. VeranomeB...
OCT 20, 2021 10:00 AM PDT
C.E. CREDITS
OCT 20, 2021 10:00 AM PDT
Date: October 20, 2021 Time:10:00am (PDT), 1:00pm (EDT) As the prevalence of Diabetes continues to rise in many areas across the globe, healthcare providers continue to look for methods that...
APR 25, 2017 10:00 AM PDT

WEBINAR: Discover Potentially Predictive Immuno-Oncology Biomarkers using Next-Gen Sequencing


Specialty

Cancer Research

Molecular Diagnostics

Molecular Biology

Clinical Diagnostics

Cancer Diagnostics

Immunology

Biomarkers

Genomics

Biotechnology

Genetics

Cancer Therapeutics

Cell Biology

Oncology

Clinical Research

Laboratory Testing

Geography

North America66%

Europe14%

Asia11%

South America4%

Oceania1%

Africa1%

Registration Source

Website Visitors100%

Job Title

Executive17%

Scientist14%

Facility/Department Manager12%

Research Scientist10%

Student10%

Educator/Faculty7%

Lab Management6%

Medical Laboratory Technician5%

Medical Doctor/Specialist5%

Post Doc3%

Marketing/Sales3%

Clinical Laboratory Scientist2%

QC/QA2%

Biologist2%

Chemist1%

Consultant1%

Pathologist1%

Organization

Biotech Company9%

Academic Institution9%

Clinical Laboratory5%

Hospital5%

Life Science Company3%

Research Institute3%

Pharmaceutical Company3%

Ambulatory Care2%

Medical School2%

Medical Center2%

Consultant1%

Industrial Company1%

Government1%

Medical Device Company1%

Other4%


Show Resources
Loading Comments...
Show Resources